Document Detail

Cell Cycle Proteins in Brain in Mild Cognitive Impairment: Insights into Progression to Alzheimer Disease.
MedLine Citation:
PMID:  22083458     Owner:  NLM     Status:  Publisher    
Recent studies have demonstrated the re-emergence of cell cycle proteins in brain as patients progress from the early stages of mild cognitive impairment (MCI) into Alzheimer's disease (AD). Oxidative stress markers present in AD have also been shown to be present in MCI brain suggesting that these events occur in early stages of the disease. The levels of key cell cycle proteins, such as CDK2, CDK5, cyclin G1, and BRAC1 have all been found to be elevated in MCI brain compared to age-matched control. Further, peptidyl prolyl cis-trans isomerase (Pin1), a protein that plays an important role in regulating the activity of key proteins, such as CDK5, GSK3-β, and PP2A that are involved in both the phosphorylation state of Tau and in the cell cycle, has been found to be oxidatively modified and downregulated in both AD and MCI brain. Hyperphosphorylation of Tau then results in synapse loss and the characteristic Tau aggregation as neurofibrillary tangles, an AD hallmark. In this review, we summarized the role of cell cycle dysregulation in the progression of disease from MCI to AD. Based on the current literature, it is tempting to speculate that a combination of oxidative stress and cell cycle dysfunction conceivably leads to neurodegeneration.
Jeriel T R Keeney; Aaron M Swomley; Jessica L Harris; Ada Fiorini; Mihail I Mitov; Marzia Perluigi; Rukhsana Sultana; D Allan Butterfield
Related Documents :
861938 - Selective incorporation of l-3,4-dihydroxyphenylalanine by s-91 cloudman melanoma in vi...
1299228 - Application of morphometric methods to the cytologic study of intradermal nevi.
20300218 - The air liquid-interface, a skin microenvironment, promotes growth of melanoma cells, b...
15200488 - Odontogenic ghost cell tumour with clear cell components: clear cell odontogenic ghost ...
21908978 - Braking with 30 fingers: znf521 holds on ebf1-dependent b-cell development.
23103668 - Prolonged stimulation with thyrotropin-releasing hormone and pituitary adenylate cyclas...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-15
Journal Detail:
Title:  Neurotoxicity research     Volume:  -     ISSN:  1476-3524     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100929017     Medline TA:  Neurotox Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Chemistry, Center for Membrane Sciences, Sanders Brown Center on Aging, University of Kentucky, Lexington, KY, 40506, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Developing a provisional definition of a flare in patients with established gout.
Next Document:  Protective Efficacy of Coenzyme Q(10) Against DDVP-Induced Cognitive Impairments and Neurodegenerati...